Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score

Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score

Objective. To examine the utility of the Framingham risk score (FRS) in estimating cardiovascular risk in psoriasis. Methods. We compared the predicted 10-year risk of cardiovascular events, namely, cardiovascular death, myocardial infarction, heart failure, percutaneous transluminal coronary angiop...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elena Myasoedova, Bharath Manu Akkara Veetil, Eric L. Matteson, Hilal Maradit Kremers, Marian T. McEvoy, Cynthia S. Crowson
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Scientifica
Online Access:	http://dx.doi.org/10.1155/2013/371569
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Framingham score in the evaluation of cardiovascular risk in diabetics
by: Mariana Costa Larré, et al.
Published: (2014-12-01)

Framingham score in the evaluation of cardiovascular risk in diabetics
by: Mariana Costa Larré, et al.
Published: (2014-12-01)

Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
by: Cosmin-Ioan MOGA, et al.
Published: (2023-01-01)

Framingham Risk Score Prediction at 12 Months in the STANDFIRM Randomized Control Trial
by: Thanh G. Phan, et al.
Published: (2025-05-01)

Nontraditional Factors Influencing Cardiovascular Disease Risk: Correlation Among Framingham Risk Score, Body Composition Index, and Sleep‐Breathing Monitoring Index
by: Libo Zhao, et al.
Published: (2025-03-01)

Cognitive impairment among older persons with chronic illness attending primary care and its association with cardiovascular risk using the Framingham risk score
by: Nimelesh Balanthiren, et al.
Published: (2024-10-01)

Ten-Year Cardiovascular Risk Estimation through the Framingham Risk Score among Commercial Motor Vehicle Drivers with High and Low Risk of Obstructive Sleep Apnea
by: Navid Sharifi, et al.
Published: (2025-03-01)

Improving the predictive capability of Framingham Risk Score for the risk of myocardial infarction based on coronary artery calcium score in healthy Singaporeans
by: Ching Yee Ivory Yeo, et al.
Published: (2024-02-01)

Assessing the association between dairy consumption and the 10-year Framingham Risk Score in women
by: Zahra Salehi, et al.
Published: (2025-04-01)

Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events.
by: Crystel M Gijsberts, et al.
Published: (2015-01-01)

Cardiovascular Risk Factors Evaluated Using the Framingham Method in a University Community Setting
by: Angela Mendoza, et al.
Published: (2025-04-01)

Hypothalamic Gliosis Is Associated With Multiple Cardiovascular Disease Risk Factors in the Framingham Heart Study
by: Justin Lo, et al.
Published: (2025-05-01)

Framingham Risk Stratification of Middle-Aged Migraineurs
by: Gyula Bank, et al.
Published: (2020-01-01)

Machine-Learning Insights from the Framingham Heart Study: Enhancing Cardiovascular Risk Prediction and Monitoring
by: Emi Yuda, et al.
Published: (2025-08-01)

10-Year Cardiovascular Disease Risk Estimation Based on Lipid Profile-Based and BMI-Based Framingham Risk Scores across Multiple Sociodemographic Characteristics: The Malaysian Cohort Project
by: Boekhtiar Borhanuddin, et al.
Published: (2018-01-01)

The associations between skin advanced glycation end-products and Framingham cardiovascular risk in different age groups
by: Yina Wang, et al.
Published: (2025-04-01)

Prevalence and Risk Factors of Gastrointestinal Disorders in Patients with Rheumatoid Arthritis: Results from a Population-Based Survey in Olmsted County, Minnesota
by: Elena Myasoedova, et al.
Published: (2011-01-01)

Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis.
by: Chiang-Ching Huang, et al.
Published: (2011-01-01)

High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.
by: Calixte Ghehi, et al.
Published: (2017-01-01)

PSORIASIS AND CARDIOVASCULAR RISK. IS THERE ANY ASSOCIATION?
by: Mateusz Gabryszewski, et al.
Published: (2024-05-01)

A lower eGFRcystatin C/eGFRcreatinine ratio is associated with greater cardiovascular risk (higher Framingham Risk Score) in Chinese patients with newly diagnosed type 2 diabetes mellitus
by: Yan Yang, et al.
Published: (2024-12-01)

Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
by: Tjeerd-Pieter van Staa, et al.
Published: (2014-01-01)

Psoriasis and cardiovascular risk: associated and protective factors
by: Luciana Agoglia, et al.
Published: (2025-08-01)

Correlation of serum apolipoprotein B with the Framingham Risk Score among a group of Iraqi subjects: a cross-sectional study
by: Israa Nather Ahmed, et al.
Published: (2025-08-01)

Prevenção das doenças cardiovasculares com base no escore de Framingham
by: Leticia Gonçalves Souza, et al.
Published: (2022-03-01)

Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01)

A polygenic risk score model for psoriasis based on the protein interactions of psoriasis susceptibility loci
by: Charalabos Antonatos, et al.
Published: (2024-11-01)

Coleoptera Taken at Framingham
by: C. A. Frost
Published: (1909-01-01)

Escore de Framingham na avaliação do risco cardiovascular em diabéticos
by: Mariana Costa Larré, et al.
Published: (2014-12-01)

Major Limitations of Cardiovascular Risk Scores
by: Ibtissam Talha, et al.
Published: (2024-01-01)

The correlation between serum vitamin D with Apo B and framingham risk score among a group of Iraqi subjects: a Cross-sectional and prospective pilot study
by: Israa Nather Ahmed, et al.
Published: (2025-07-01)

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations.
by: Michiel Rienstra, et al.
Published: (2016-01-01)

The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study.
by: Michelle T Long, et al.
Published: (2016-01-01)

Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?
by: Sirje Kaur, et al.
Published: (2017-01-01)

Deriving Cyber Security Risks from Human and Organizational Factors – A Socio-technical Approach
by: Thomas Richard McEvoy, et al.
Published: (2019-04-01)

Foot disorders, foot posture, and foot function: the Framingham foot study.
by: Thomas J Hagedorn, et al.
Published: (2013-01-01)

Correction: The correlation between serum vitamin D with Apo B and framingham risk score among a group of Iraqi subjects: a cross-sectional and prospective pilot study
by: Israa Nather Ahmed, et al.
Published: (2025-08-01)

William Kannel y el estudio Framingham
by: Eduardo Álvarez Acevedo
Published: (2022-04-01)

Plasma proteomics-based risk scores for psoriasis prediction: a novel approach to early diagnosis
by: Siyu Wei, et al.
Published: (2025-07-01)

Identification of specific risk factors and predictive analytics for cardio-cerebral arterial stenosis: a comparative study utilizing framingham risk stratification insights
by: Gege Zhang, et al.
Published: (2025-02-01)